Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

16 results
Display

Low-Dose Adefovir-Induced Hypophosphatemic Osteomalacia on Whole-Body Bone Scintigraphy

Kim SH, Won KS, Song BI, Jo I, Zeon SK

  • KMID: 2313173
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):294-296.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Global Hepatic Uptake of 99mTc-MAA During VQ Scintigraphy Secondary to Synchronous Superior and Inferior Vena Caval Obstruction: a Demonstration of Trans-Portal Venous Collateral Pathways

Conway O, Lloyd S, Gruning T

  • KMID: 2313172
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):291-293.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Toxoplasmic Lymphadenitis Mimicking a Metastatic Thyroid Carcinoma at 18F-FDG-PET/CT

Treglia G, Bongiovanni M, Ceriani L, Paone G, Giovanella L

  • KMID: 2313171
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):289-290.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional Detection of Multiple Osteomas in a Patient with Gardner's Syndrome by Bone SPECT/CT

Kim WH, Kim DW, Kim CG, Kim MH

  • KMID: 2313174
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):297-298.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
18F-FDG PET-CT-Negative Recurrent High-Grade Anaplastic Astrocytoma Detected by 18F-FDOPA PET-CT

Karunanithi S, Singh H, Sharma P, Gupta DK, Bal C

  • KMID: 2313175
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):299-300.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Skin Manifestation of Unsuspecting Prostate Cancer Detected by 18F-FDG PET/CT Performed To Assess Underlying Multiple Myeloma

AbAziz A, Mahaletchumy T, Chung JK

  • KMID: 2313170
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):285-288.
BACKGROUND: Skin metastases from either prostate adenocarcinoma or multiple myeloma rarely occur. We report the case of a 73-year-old man with multiple myeloma who presented with multiple subcutaneous nodules 3...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Conversion to Paradoxical Finding on Technetium-99m-labeled RBC Scintigraphy after Treatment for Secondary Raynaud's Phenomenon

Chong A, Ha JM, Song HC, Kim J, Choi SJ

  • KMID: 2313168
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):278-280.
An 18-year-old woman reported that after exposure to cold temperatures her fingers appeared blue and her hands and feet felt cold. Secondary Raynaud's phenomenon (RP) associated with peripheral vascular disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radioimmunotherapy with 131I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with 90Y-Ibritumomab Tiuxetan

Kang GW, Kang HJ, Shin DY, Gu HR, Choi HS, Lim SM

  • KMID: 2313169
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):281-284.
We report a case that demonstrates the efficacy of radioimmunotherapy (RIT) with radioiodinated rituximab (131I-rituximab) for relapsed diffuse large B-cell lymphoma (DLBCL). A 79-year-old male patient with DLBCL initially achieved...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristic Uptake Pattern of Bone Scintigraphy in Patients with Hepatocellular Carcinoma Following Treatment with High-Intensity Focused Ultrasound

Ma WH, Ho WY, Lai AS, Wong KK, Law M

  • KMID: 2313167
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):273-277.
PURPOSE: This study retrospectively reviews the characteristic bone scintigraphic findings in 18 patients with hepatocellular carcinoma (HCC) following treatment with high-intensity focused ultrasound (HIFU). A potential complication of HIFU is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Limited Clinical Value of Periablative Changes of Serum Markers in the Prediction of Biochemical Remission in Patients with Papillary Thyroid Cancer

Kim H, Kim SJ, Kim IJ, Kim K, Kim S, Kim BH, Kim SS, Kyung JY

  • KMID: 2313166
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):268-272.
PURPOSE: Remnant thyroid ablation and 1-year stimulated thyroglobulin (sTg) measurement are recommended for those who have undergone total thyroidectomy for differentiated thyroid cancer. The serum Tg kinetics in such patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Impact of Energy Substrates, Hormone Level and Subject-Related Factors on Physiologic Myocardial 18F-FDG Uptake in Normal Humans

Jeong J, Kong E, Chun K, Cho I

  • KMID: 2313160
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):225-231.
PURPOSE: In a whole-body 18F-FDG PET/CT, non-specific 18F-FDG uptake of the myocardium is a common finding and can be very variable, ranging from background activity to intense accumulation and inhomogeneity....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Heterogeneity Analysis of 18F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting

Budiawan H, Cheon GJ, Im HJ, Lee SJ, Paeng JC, Kang KW, Chung JK, Lee DS

  • KMID: 2313161
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):232-241.
PURPOSE: Lymph node (LN) characterization is crucial in determining the stage and treatment decisions in patient with lung cancer. Although 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has a higher...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Value of F-18 FDG PET for Planning Treatment and Detecting Recurrence in Malignant Salivary Gland Tumors: Comparison with Conventional Imaging Studies

Park HL, Yoo IR, Lee N, Yoon H, Choi EK, Choi HS, Kim SH

  • KMID: 2313162
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):242-248.
PURPOSE: To assess the value of F-18 FDG PET/CT for detecting cervical lymph node (LN) metastasis and recurrence, as well as planning treatment, and to compare the accuracy of PET/CT...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Value of Metabolic Activity Measured by 18F-FDG PET/CT in Patients with Advanced Endometrial Cancer

Kim HJ, Choi J, Jeong YH, Jo KH, Lee JH, Cho A, Yun M, Lee JD, Kim YT, Kang WJ

  • KMID: 2313164
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):257-262.
PURPOSE: We evaluated the potential prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with stage IIIC/IV endometrial cancer. METHODS: Patients with stage IIIC/IV endometrial cancer who had...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
18F-FDG PET in Patients with Primary Systemic Anaplastic Large Cell Lymphoma: Differential Features According to Expression of Anaplastic Lymphoma Kinase

Lee DY, Lee JJ, Kim JY, Park SH, Chae SY, Kim S, Yoon DH, Suh C, Huh J, Ryu JS

  • KMID: 2313163
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):249-256.
PURPOSE: Primary systemic anaplastic large cell lymphoma (ALCL) is divided into two entities according to the expression of anaplastic lymphoma kinase (ALK). We investigated 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prognostic Value of 18F-FDG PET/CT for Early Recurrence in Operable Breast Cancer: Comparison with TNM Stage

O JH, Choi WH, Han EJ, Choi EK, Chae BJ, Park YG, Kim SH

  • KMID: 2313165
  • Nucl Med Mol Imaging.
  • 2013 Dec;47(4):263-267.
PURPOSE: We evaluated whether the maximum standardized uptake values (SUVmax) of primary tumor from the initial staging by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) of patients with breast cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr